Font Size: a A A
Keyword [Esophageal squamous cell carcinoma(ESCC)]
Result: 121 - 136 | Page: 7 of 7
121. DIAPH3 Promotes Proliferation,Migration And Invasion Of Esophageal Squamous Cell Carcinoma And Its Molecular Mechanisms
122. Vortioxetine Inhibits The Proliferation Of Esophageal Squamous Cell Carcinoma(ESCC) By Downregulating CDK4/6-RB1 Signaling Pathway
123. LncRNA XIST Affects The Progression Of Esophageal Squamous Cell Carcinoma (ESCC) By Regulating The MiR-129-5p/CCND1 Signaling Axis
124. The Mechanism Study Of Mefloquine Inhibits Esophageal Squamous Cell Carcinoma Proliferation
125. Exploratory Study Of Neutrophil-to-lymphocyte Ratio And Human Leukocyte Antigen Class I Genotyping As Potential Biomarkers For Immunotherapy In Esophageal Squamous Cell Carcinoma
126. Mechanism Research Of MicroRNA-181a-5p Inhibiting The Progression Of Esophageal Squamous Cell Carcinoma Via ERK-MMP Signaling Pathway
127. The Role And Mechanism Of GPNMB In The Progression Of Esophageal Squamous Cell Carcinoma
128. CircCRIM1 Regulates TCF12 By Interacting MiR-342-3p To Promote Epithelial-mesenchymal Transition Of Esophageal Squamous Cell Carcinoma
129. The Mechanism Of PIWIL2 Regulating Autophagy And Apoptosis In Esophageal Squamous Cell Carcinoma Via Competitively Binding IKK With TSC
130. The Effects And Mechanism Of Scaffold Protein IQGAP1 On Paclitaxel Chemotherapy Resistance By Regulating Ferroptosis In Esophageal Squamous Cell Carcinoma Cells
131. Study On The Synergistic Inhibitory Effect Of YAP Inhibitor Verteporfin Combined With Cisplatin On Esophageal Squamous Cell Carcinoma Cells
132. Analysis Of Risk Factors For Cervical Lymph Node Metastasis In Esophageal Squamous Cell Carcinoma And Establishment Of Risk Prediction Model
133. Application Of PET-CT Radiomics In The Treatment Of Pathological Complete Response By Neoadjuvant Immunotherapy Combined With Chemotherapy In Patients With Esophageal Squamous Cell Carcinoma
134. Predictive Value Of The Presence Of Prevotella And The Ratio Of Porphyromonas Gingivalis To Prevotella In Saliva For Esophageal Squamous Cell Carcinoma
135. The Expression Of Nerve Growth Factor And Tyrosine Kinase Receptor A In Esophageal Squamous Cell Carcinoma Tissue And Its Clinical Significance
136. Comparison Of The Efficiacy And Safety Of Preoperative Neoadjuvant Chemotherapy Combined With Sintilimab And Neoadjuvant Chemotherapy Alone In The Treatment Of Locally Advanced Esophageal Squamous Cell Carcinoma
  <<First  <Prev  Next>  Last>>  Jump to